Sunshine Biopharma Ownership | Who Owns Sunshine Biopharma?

Sunshine Biopharma Ownership Summary

100.00% retail investors. Rise advisors is the largest institutional shareholder, holding 0% of SBFM shares. DFA Emerging Markets I is the top mutual fund, with 0.26% of its assets in Sunshine Biopharma shares.

SBFM Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sunshine Biopharma	-	-	100.00%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Specialty & Generic Drug Manufacturers Stocks	34.90%	10.53%	54.58%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rise advisors	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rise advisors	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Rise advisors	-	-	-18.00

Top Sellers

Holder	Shares	% Assets	Change
Rise advisors	-	-	-18.00

Sold Out

Holder	Change
Rise advisors	-18.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2024	1	-	18	-	-	35714.29%	-	-	-	-
Dec 31, 2023	1	-	18	-	-	35714.29%	-	-	-	-
Sep 30, 2023	1	-	18	-	-	35714.29%	-	-	-	-
Jun 30, 2023	1	-50.00%	18	-52.63%	-	8028.81%	-	-	-	-100.00%
Mar 31, 2023	2	-	38	-87.86%	-	248.77%	-	-100.00%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
DFA Emerging Markets I	5.18K	0.26%	5.18K
DFA Emerging Markets II	58.00	0.00%	58.00
Fidelity Nasdaq Composite Index	11.00	0.00%	1.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 04, 2024	Slilaty Steve N.	Chief Executive Officer	Buy	$10.00K
Feb 08, 2024	Slilaty Steve N.	Chief Executive Officer	Buy	$2.00K
Nov 30, 2022	Sebaaly Camille	CFO/Secretary	Buy	$22.91K
Jun 03, 2022	Sebaaly Camille	CFO/Secretary	Buy	$30.50K
Apr 12, 2016	Slilaty Steve N.	Chief Executive Officer	Buy	$50.01K

Insider Transactions Trends

Date	Buy	Sell
2024 Q1	2	-
2022 Q4	1	-
2022 Q2	1	-
2022 Q1	-	-
2021 Q4	-	-

SBFM Ownership FAQ

Who Owns Sunshine Biopharma?

Sunshine Biopharma shareholders are primarily institutional investors at 0.00%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Sunshine Biopharma's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.90%, which Sunshine Biopharma falls below.

Does Blackrock own Sunshine Biopharma?

BlackRock is not among the top 10 institutional shareholders of Sunshine Biopharma.

Who is Sunshine Biopharma’s biggest shareholder by percentage of total assets invested?

Rise advisors is Sunshine Biopharma’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Sunshine Biopharma shares, valued at 0$.

Who is the top mutual fund holder of Sunshine Biopharma shares?

DFA Emerging Markets I is the top mutual fund holder of Sunshine Biopharma shares, with 0.26% of its total shares outstanding invested in 5.18K Sunshine Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools